<Application input="Single">
  <ApplicationInfo input="Single">
    <RoundId input="None"></RoundId>
    <RoundName input="None"></RoundName>
    <ApplicationIdentifier input="None"></ApplicationIdentifier>
    <ApplicationType input="None"></ApplicationType>
    <CopiedFromOriginal input="None"></CopiedFromOriginal>
    <CopiedFrom input="None"></CopiedFrom>
    <ResponseVersion input="None"></ResponseVersion>
    <ApplicationTitle input="None"></ApplicationTitle>
    <StartDate input="None"></StartDate>
    <EndDate input="None"></EndDate>
    <InterestedParties input="None"></InterestedParties>
    <InterestedPartiesOrganisation input="None"></InterestedPartiesOrganisation>
    <CreatedDate input="None"></CreatedDate>
  </ApplicationInfo>
  <q1 input="Default" question="Acknowledge and Continue">Acknowledge and Continue</q1>
  <q693 input="Text" question="Q1.1 What is the Project Title (as presented in the Project Description/Protocol)? *">Sample Project</q693>
  <q694 input="Text" question="Q1.2 Provide a summary of the research project in non-technical language.*">A sample project to develop an automation of data entry</q694>
  <q1450 input="Text" question="Q1.3 Which category/ies of research best describes the project? *">A brief description of the project categories</q1450>
  <q1455 input="Multi" question="Q1.4 In what environment/s will the research be conducted? *"></q1455>
  <q1456 input="Text" question="Q1.4.1 Specify the other environment *">Sample environment</q1456>
  <q1462 input="Text" question="Q1.5 What organisation/entity has overall responsibility for this project? *">Sample organisation</q1462>
  <q800 input="Text" question="Q1.6 Describe how this research project is currently, or will be, funded.*">Sample funding</q800>
  <q1325 input="Date or Check" question="Q1.7 When do you anticipate starting the research project? *"></q1325>
  <q1232 input="Int w/ Drop" question="Q1.8 What is the anticipated duration of the research project? *"></q1232>
  <TeamMembersRpt input="Repeatable">
    <q645 input="Text" question="Q1.9.1 Title">Mr</q645>
    <q646 input="Text" question="Q1.9.2 First Name *">First</q646>
    <q647 input="Text" question="Q1.9.3 Surname/family name *">User</q647>
    <q649 input="Text" question="Q1.9.4 Email Address *">first.user@uq.edu.au</q649>
    <q668 input="Yes/No" question="Q1.9.5 Is this person the contact person for this application? *"></q668>
    <q669 input="" question="Q1.9.5.1 Contact Email Address *"></q669>
    <q671 input="" question="Q1.9.5.2 Contact Phone Number *"></q671>
    <q672 input="" question="Q1.9.5.3 Contact Mailing Address *"></q672>
    <q656 input="Yes/No" question="Q1.9.6 Is this person a student on this project? *"></q656>
    <q702 input="" question="Q1.9.6.1 Describe the supervisory arrangements, support and training.*"></q702>
    <q659 input="" question="Q1.9.6.2 Identify the student’s educational program.*"></q659>
    <q660 input="" question="Q1.9.6.2.1 Name of the educational program *"></q660>
    <q701 input="" question="Q1.9.7 Institutional affiliation and position *"></q701>
    <q653 input="" question="Q1.9.8 Staff ID"></q653>
    <q654 input="" question="Q1.9.9 ORCID ID"></q654>
    <q835 input="" question="Q1.9.10 What is the position of this person on the research project? *"></q835>
    <q836 input="" question="Q1.9.10.1 Name of position *"></q836>
    <q1442 input="" question="Q1.9.11 Does this person have authorisation to sign the application on behalf of all members of the research team? *"></q1442>
    <q703 input="" question="Q1.9.12 Describe the research activities this person will be responsible for.*"></q703>
    <q704 input="" question="Q1.9.13 Describe the person’s expertise relevant to the research activity.*"></q704>
  </TeamMembersRpt>
  <TeamMembersRpt>
    <q645 input="Text" question="Q1.9.1 Title">Mr</q645>
    <q646 input="Text" question="Q1.9.2 First Name *">First</q646>
    <q647 input="Text" question="Q1.9.3 Surname/family name *">User</q647>
    <q649 input="" question="Q1.9.4 Email Address *">first.user@uq.edu.au</q649>
    <q668 input="" question="Q1.9.5 Is this person the contact person for this application? *"></q668>
    <q669 input="" question="Q1.9.5.1 Contact Email Address *"></q669>
    <q671 input="" question="Q1.9.5.2 Contact Phone Number *"></q671>
    <q672 input="" question="Q1.9.5.3 Contact Mailing Address *"></q672>
    <q656 input="" question="Q1.9.6 Is this person a student on this project? *"></q656>
    <q702 input="" question="Q1.9.6.1 Describe the supervisory arrangements, support and training.*"></q702>
    <q659 input="" question="Q1.9.6.2 Identify the student’s educational program.*"></q659>
    <q660 input="" question="Q1.9.6.2.1 Name of the educational program *"></q660>
    <q701 input="" question="Q1.9.7 Institutional affiliation and position *"></q701>
    <q653 input="" question="Q1.9.8 Staff ID"></q653>
    <q654 input="" question="Q1.9.9 ORCID ID"></q654>
    <q835 input="" question="Q1.9.10 What is the position of this person on the research project? *"></q835>
    <q836 input="" question="Q1.9.10.1 Name of position *"></q836>
    <q1442 input="" question="Q1.9.11 Does this person have authorisation to sign the application on behalf of all members of the research team? *"></q1442>
    <q703 input="" question="Q1.9.12 Describe the research activities this person will be responsible for.*"></q703>
    <q704 input="" question="Q1.9.13 Describe the person’s expertise relevant to the research activity.*"></q704>
  </TeamMembersRpt>
  <q54 input="" question="Q1.10 Do any members of the research team (including persons not listed in this application), have any financial or non-financial interests related to this research? *"></q54>
  <q710 input="" question="Q1.10.1 Explain the nature and extent of the interests and to which member of the team they apply.*"></q710>
  <q711 input="" question="Q1.10.2 Explain how you intend to manage these interests and any potential conflicts that may arise.*"></q711>
  <q59 input="" question="Q1.11 Are there any restrictions or limits on publication of data or dissemination of research outcomes of this project?*"></q59>
  <q712 input="" question="Q1.11.1 Detail the restrictions or limits on publication of data arising from the research project and explain how these will be balanced with relevant accessibility expectations. *"></q712>
  <q62 input="" question="Q1.12 Has the scientific or academic merit of the research project been evaluated?*"></q62>
  <q713 input="" question="Q1.12.1 What was the review process and what was the outcome? *"></q713>
  <q479 input="" question="Q1.12.2 Attach evidence of the outcome of the scientific or academic review process."></q479>
  <q778 input="" question="Q1.13 Has this research project had prior ethics review?*"></q778>
  <EthicsEvaluationRpt input="">
    <q852 input="" question="Q1.13.1 Which ethics committee previously reviewed the application? *"></q852>
    <q782 input="" question="Q1.13.2 What was the outcome of the prior ethics review? *"></q782>
    <q783 input="" question="Q1.13.2.1.1 Attach evidence of the outcome of the prior ethics review process. *"></q783>
    <q1202 input="" question="Q1.13.2.2.1 Provide the ethics committee's reason/s for not approving the research project. *"></q1202>
  </EthicsEvaluationRpt>
  <q1237 input="" question="Q1.14 Will any further or additional specialised review of this application be sought?*"></q1237>
  <SpecialistEvaluationRpt input="">
    <q1235 input="" question="Q1.14.1 Name of entity conducting specialist review. *"></q1235>
    <q1236 input="" question="Q1.14.2 When review will be sought. *"></q1236>
  </SpecialistEvaluationRpt>
  <q788 input="" question="Q1.15 Will this research project be conducted at multiple sites? *"></q788>
  <q1452 input="" question="Q1.16 Will separate institutional approvals or authorisations be required prior to commencing research at each site?*"></q1452>
  <q72 input="" question="Q1.17 From the list below, select all the research methods that will be used in the research project.*"></q72>
  <q74 input="" question="Q1.18 Indicate with whom or with what the research will be conducted*"></q74>
  <q1471 input="" question="Q1.18.1 Does your research involve the prospective collection of data? *"></q1471>
  <q75 input="" question="Q1.19 Will your research involve participation of any of the following?"></q75>
  <q527 input="" question="M1.1 What is the challenge, need, phenomenon or question that the research will explore? *"></q527>
  <q526 input="" question="M1.2 What process/es will be used to refine the objectives and design of the research, and how frequently will this be repeated during the project? *"></q526>
  <q857 input="" question="M1.3 What outputs do you anticipate will be generated by the research? *"></q857>
  <q862 input="" question="M2.1 What type/s of human biospecimen/s will be collected and used? *"></q862>
  <q137 input="" question="M2.2 Will you be collecting biospecimens prospectively? *"></q137>
  <q535 input="" question="M2.2.1 How, and from whom, will you be obtaining these biospecimens? *"></q535>
  <q138 input="" question="M2.3 Will you be using biospecimens from one or more existing archives or biobanks? *"></q138>
  <BioBankRpt input="">
    <q865 input="" question="M2.3.1 Name of archive or biobank *"></q865>
    <q866 input="" question="M2.3.2 Do you have confirmation that you can access the biospecimens? *"></q866>
    <q1091 input="" question="M2.3.3 Is your use of the biospecimens consistent with the consent obtained at the time the biospecimens were collected?*"></q1091>
    <q1092 input="" question="M2.3.3.1 Attach any available evidence of the consent obtained at the time the biospecimens were collected."></q1092>
  </BioBankRpt>
  <q141 input="" question="M2.4 Will you be importing and/or exporting biospecimens internationally?*"></q141>
  <ImportedBiospecimensRpt input="">
    <q870 input="" question="M2.4.1.1 What is the source of the biospecimens? *"></q870>
    <q871 input="" question="M2.4.1.2 Do you have confirmation that you can access the biospecimens? *"></q871>
    <q872 input="" question="M2.4.1.2.1 Who provided the confirmation? *"></q872>
    <q873 input="" question="M2.4.1.2.2 Attach evidence of the confirmation."></q873>
  </ImportedBiospecimensRpt>
  <q1239 input="" question="M2.4.1.3 How will you ensure that the research meets the guidance provided in National Statement 3.2.7 and, if applicable, National Statement 3.2.10 regarding the use of imported biospecimens?*"></q1239>
  <ExportedBiospecimensRpt input="">
    <q879 input="" question="M2.4.2.1 Name of entity to whom the biospecimens are being exported. *"></q879>
    <q880 input="" question="M2.4.2.2 Location of the entity to whom the biospecimens are being exported. *"></q880>
  </ExportedBiospecimensRpt>
  <q1241 input="" question="M2.4.2.3 How will you ensure that the research meets the guidance provided in National Statement 3.2.9 regarding the exportation of biospecimens?*"></q1241>
  <q144 input="" question="M2.5 Will you be obtaining post-mortem biospecimens? *"></q144>
  <q143 input="" question="M2.6 Will you be performing any genetic or genomic testing, investigation or analysis of the biospecimens?*"></q143>
  <q1242 input="" question="M2.7 Will the biospecimens be destroyed at the conclusion of the project or will they be retained for future use? *"></q1242>
  <q1243 input="" question="M2.7.1.1 How will the biospecimens be destroyed? *"></q1243>
  <q804 input="" question="M2.7.2.1 Describe which biospecimens will be retained, any intended future use/s and any arrangements for future access to the biospecimens?*"></q804>
  <q538 input="" question="M2.8 Having regard to the answers to the above questions, describe any ethical considerations related to your collection, use and analysis of biospecimens.*"></q538>
  <q891 input="" question="M3.1 How will your research/findings account for any limitations arising from your choice of data sets/databases or from missing data?*"></q891>
  <q681 input="" question="M3.2 How will you control for confounding factors or other vulnerabilities toward bias in your research?*"></q681>
  <q894 input="" question="M3.3 How will you manage any risk that linking databases of non-identifiable data could subsequently result in the individuals being identified?*"></q894>
  <q885 input="" question="M4.1 How will you distinguish between participants and non-participants in your research, and how will you manage that distinction?*"></q885>
  <q883 input="" question="M5.1 What population/s will be studied? *"></q883>
  <q515 input="" question="M6.1 Briefly describe the intervention/s that you will be using.*"></q515>
  <q906 input="" question="M6.2 Is your intervention related to the prevention, diagnosis, treatment or management of a health condition? *"></q906>
  <q93 input="" question="M6.2.1 Do you consider that you are conducting a clinical trial?*"></q93>
  <q1125 input="" question="M6.2.1.1 What does the clinical trial involve the use of?*"></q1125>
  <InterventionalDrugRpt input="">
    <q1160 input="" question="M6.2.1.1.1.1 Approved Name *"></q1160>
    <q1161 input="" question="M6.2.1.1.1.2 Trade Name (if any) Optional"></q1161>
    <q1162 input="" question="M6.2.1.1.1.3 Manufacturer of drug *"></q1162>
    <q1163 input="" question="M6.2.1.1.1.4 Supplier of drug (e.g. pharmacy/manufacturer) *"></q1163>
    <q1164 input="" question="M6.2.1.1.1.5 Approved therapeutic indication, dosage/duration in Australia (if applicable)*"></q1164>
    <q1165 input="" question="M6.2.1.1.1.6 Believed mode of action *"></q1165>
    <q1166 input="" question="M6.2.1.1.1.7 Dosage regimen *"></q1166>
    <q1167 input="" question="M6.2.1.1.1.8 Mode of excretion *"></q1167>
    <q1168 input="" question="M6.2.1.1.1.9 Known adverse events *"></q1168>
    <q1169 input="" question="M6.2.1.1.1.10 Known contra-indications or warnings *"></q1169>
    <q1170 input="" question="M6.2.1.1.1.11 Is this the first use of the drug in humans? *"></q1170>
    <q1171 input="" question="M6.2.1.1.1.12 Is this the first use of the drug in patients? *"></q1171>
    <q1172 input="" question="M6.2.1.1.1.13 Is the drug registered in Australia by the Therapeutic Goods Administration? *"></q1172>
    <q1173 input="" question="M6.2.1.1.1.13.1 Under what name is the drug registered? *"></q1173>
    <q1174 input="" question="M6.2.1.2.3.13.2 Provide the ARTG Number *"></q1174>
    <q1175 input="" question="M6.2.1.1.1.14 Is the drug dosage, administration, indications for use and/or age group of participants proposed for this project different from the Australian approved product information? *"></q1175>
    <q1176 input="" question="M6.2.1.1.1.14.1 Provide justification, including a summary of the most up-to-date information, to support the unapproved use of the drug in this project. *"></q1176>
    <q1177 input="" question="M6.2.1.1.1.15 Has the drug been registered/licensed/approved for marketing for this indication by an international regulatory authority (other than the Australian Therapeutic Goods Administration)? *"></q1177>
    <q1474 input="" question="M6.2.1.1.1.15.1 Identify the countries and/or regulatory authorities that have registered, licensed or approved the drug.*"></q1474>
    <q1179 input="" question="M6.2.1.1.1.16 Has the drug been registered, licensed or approved for marketing for other indications by an international regulatory authority (other than the Australian Therapeutic Goods Administration)? *"></q1179>
    <q1180 input="" question="M6.2.1.1.1.16.1 Identify countries and/or regulatory authorities that have registered, licensed or approved the drug and give details of the other indication(s) for which the drug is registered, licensed or approved.*"></q1180>
    <q1181 input="" question="M6.2.1.1.1.16.2 Provide details of the other indication/s for which the drug is registered, licensed or approved. *"></q1181>
    <q1182 input="" question="M6.2.1.1.1.17 Has the drug been reviewed for investigational or research uses by an international regulatory authority? *"></q1182>
    <q1184 input="" question="M6.2.1.1.1.17.1 Provide evidence of the review.*"></q1184>
    <q1186 input="" question="Provide evidence of the review.Optional"></q1186>
    <q1187 input="" question="M6.2.1.1.1.17.2 Did the international regulatory authority/ies raise any objections? *"></q1187>
    <q1188 input="" question="M6.2.1.1.1.17.2.1 Provide details of the objections raised and how you have addressed them.*"></q1188>
  </InterventionalDrugRpt>
  <InterventionalDeviceRpt input="">
    <q1095 input="" question="M6.2.1.1.2.1 Approved Name *"></q1095>
    <q1096 input="" question="M6.2.1.1.2.2 Trade Name (if any) Optional"></q1096>
    <q1097 input="" question="M6.2.1.1.2.3 Manufacturer of device *"></q1097>
    <q1098 input="" question="M6.2.1.1.2.4 Supplier of device *"></q1098>
    <q1099 input="" question="M6.2.1.1.2.5 Approved therapeutic indication, duration in Australia *"></q1099>
    <q1104 input="" question="M6.2.1.1.2.6 Known adverse events *"></q1104>
    <q1105 input="" question="M6.2.1.1.2.7 Known contra-indications or warnings *"></q1105>
    <q1047 input="" question="M6.2.1.1.2.8 Is this the first use of the device in humans? *"></q1047>
    <q1048 input="" question="M6.2.1.1.2.9 Is this the first use of the device in patients? *"></q1048>
    <q1049 input="" question="M6.2.1.1.2.10 Is the device included on the Australian Register of Therapeutic Goods (ARTG)?"></q1049>
    <q1050 input="" question="M6.2.1.1.2.10.1 Under what name is the device registered? *"></q1050>
    <q1108 input="" question="M6.2.1.1.2.10.2 Provide the ARTG Number *"></q1108>
    <q1051 input="" question="M6.2.1.1.2.11 Is the application of the device proposed in this project different from the application/s of the device included on the ARTG? *"></q1051>
    <q1052 input="" question="M6.2.1.1.2.11.1 Provide justification to support the use of an unregistered product in this project. *"></q1052>
    <q1053 input="" question="M6.2.1.1.2.12 Has the device been registered/licensed/approved for marketing for this indication by an international regulatory authority (other than the Australian Therapeutic Goods Administration)? *"></q1053>
    <q1119 input="" question="M6.2.1.1.2.12.1 Identify the countries and/or regulatory authorities that have registered, licensed or approved the device.*"></q1119>
    <q1055 input="" question="M6.2.1.1.2.13 Has the device been registered, licensed or approved for marketing for other indications by an international regulatory authority (other than the Australian Therapeutic Goods Administration)? *"></q1055>
    <q1120 input="" question="M6.2.1.1.2.13.1 Identify the countries and/or regulatory authorities that have registered, licensed or approved the device.*"></q1120>
    <q1121 input="" question="M6.2.1.1.2.13.2 Provide details of the other indication/s for which the device is registered, licensed or approved. *"></q1121>
    <q1058 input="" question="M6.2.1.1.2.14 Has the device been reviewed for investigational or research uses by an international regulatory authority? *"></q1058>
    <q1124 input="" question="M6.2.1.1.2.14.1 Provide evidence of the review.*"></q1124>
    <q1115 input="" question="Provide evidence of the review. Optional"></q1115>
    <q1060 input="" question="M6.2.1.1.2.14.2 Did the international regulatory authority/ies raise any objections? *"></q1060>
    <q1061 input="" question="M6.2.1.1.2.14.2.1 Provide details of the objections raised and how you have addressed them."></q1061>
  </InterventionalDeviceRpt>
  <q1634 input="" question="M6.2.1.1.3.1 Describe the ethical considerations related to your xenotransplantation research and your strategies for addressing and managing these issues? *"></q1634>
  <q1636 input="" question="M6.2.1.1.3.2 Attach an ethically defensible plan for the management of risks related to xenotransplantation research. *"></q1636>
  <q1085 input="" question="M6.2.1.2 Does the clinical trial differ from standard care? *"></q1085>
  <q516 input="" question="M6.2.1.2.1 How does the clinical trial differ from standard care? *"></q516>
  <q97 input="" question="M6.2.1.3 Will trial participants be exposed to ionising radiation to which they would not have been exposed to if they did not participate in the trial?*"></q97>
  <q517 input="" question="M6.2.1.3.1 What evidence will you be providing that you have complied with the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) requirements regarding ionising radiation? *"></q517>
  <q102 input="" question="M6.2.1.2.4 Will your clinical trial be conducted under either the Clinical Trial Notification (CTN) or Clinical Trial Exemption (CTX) schemes?*"></q102>
  <q103 input="" question="M6.2.1.2.4.1 Do you want to complete your eCTN now? *"></q103>
  <q1464 input="" question="M6.2.1.2.5 Who is the sponsor of the clinical trial?*"></q1464>
  <InterventionalSitesRpt input="">
    <q790 input="" question="M6.2.1.2.6.1 Name of site *"></q790>
    <q789 input="" question="M6.2.1.2.6.2 Individual responsible at site *"></q789>
  </InterventionalSitesRpt>
  <q105 input="" question="M6.2.1.2.7 Select the phase or class of your clinical trial.*"></q105>
  <q106 input="" question="M6.2.1.2.8 Has this clinical trial been registered on a Primary Registry in the World Health Organization Registry Network?*"></q106>
  <q108 input="" question="M6.2.1.2.8.1 Provide the clinical trial registration number/identifier. *"></q108>
  <q109 input="" question="M6.2.1.2.8.2 Do you want to register your trial with the Australian New Zealand Clinical Trials Registry (ANZCTR) now?*"></q109>
  <q913 input="" question="M6.2.1.2.9 Do you intend to make the trial intervention available to participants after the completion of the trial? *"></q913>
  <q914 input="" question="M6.2.1.2.9.1 Explain the arrangements for post-trial access to the trial intervention.*"></q914>
  <q1590 input="" question="M6.2.1.2.10 Explain how and when participants will be informed about post-trial access to the trial intervention.*"></q1590>
  <q917 input="" question="M6.2.2.1 In what context and with whom will you be conducting your interventional research?"></q917>
  <q1414 input="" question="M6.3 With regard to your answers above, describe any ethical considerations related to your use of the intervention/s in this research project and your plans for addressing these issues.*"></q1414>
  <q887 input="" question="M7.1 What type of observation will you be conducting?*"></q887>
  <q888 input="" question="M7.2 What sampling strategy will you use? *"></q888>
  <q889 input="" question="M7.3 How will you match and follow up participants? *"></q889>
  <q531 input="" question="M7.4 How will potential sources of bias be addressed, including consideration of both the direction and magnitude of bias? *"></q531>
  <q896 input="" question="M8.1 What process/es will your research project use? *"></q896>
  <q897 input="" question="M8.2 How will you engage with your participants? *"></q897>
  <q899 input="" question="M8.3 How will personal identifiers be retained or removed over the course of your project?*"></q899>
  <q900 input="" question="M8.4 Will participants have the opportunity to review or edit their responses or contributions prior to data analysis or publication? *"></q900>
  <q1040 input="" question="M8.4.1.1 Indicate the relevant section/s of your Project Description that details this opportunity."></q1040>
  <q1089 input="" question="M8.4.2.1 Explain why the participants will not have the opportunity to review or edit their responses or contributions prior to data analysis or publication."></q1089>
  <q903 input="" question="M8.5 Is it foreseeable that your project will explore topics that may cause distress for participants?*"></q903>
  <q533 input="" question="M9.1 In what way do you consider your research to be human research? *"></q533>
  <q147 input="" question="P1.1 Who will the research involve:*"></q147>
  <q541 input="" question="P1.1.1 Explain why there are no suitable alternatives by which the aims of the research can be achieved, as required by National Statement 4.1.12. *"></q541>
  <q149 input="" question="P1.2 Is there a foreseeable impact on the fetus in utero? *"></q149>
  <q539 input="" question="P1.3 How will the wellbeing of the pregnant woman and fetus be managed? *"></q539>
  <q540 input="" question="P1.4 Describe any arrangements for counselling that will be provided or made available to the women.*"></q540>
  <q542 input="" question="P1.5 How will you ensure that the research meets the guidance provided in National Statement 4.1.20 regarding the information that should be provided to female participants?*"></q542>
  <q157 input="" question="P1.6 Will the research involve the removal of organs or tissues from fetuses that have been delivered dead? *"></q157>
  <q543 input="" question="P1.6.1 How will you ensure that the research meets the guidance provided in National Statement 4.1.22 regarding the removal of organs or tissue from a fetus?*"></q543>
  <q159 input="" question="P1.7 Will fetal cells be derived from fetal tissue and stored or propagated, or will the tissue or cells be used for human transplantation?*"></q159>
  <q1591 input="" question="P1.7.1 How will you ensure that the research meets the guidance provided in National Statement 4.1.23 regarding obtaining consent for this derivation or use?*"></q1591>
  <q930 input="" question="P2.1 How will the children or young people participate in this research? *"></q930>
  <q1090 input="" question="P2.2 Explain how the research is likely to advance knowledge about the health or welfare or other matters relevant to children or young people. *"></q1090>
  <q544 input="" question="P2.3 Explain how the children’s or young people’s participation is indispensable to the conduct of the research. *"></q544>
  <q545 input="" question="P2.4 How will you ensure that the children’s and/or young people’s safety, emotional and psychological security and wellbeing are protected? *"></q545>
  <q546 input="" question="P2.5 How will you establish that participation in the research is not contrary to the best interests of the children or young people? *"></q546>
  <q220 input="" question="P3.1 Who will the research involve? *"></q220>
  <q547 input="" question="P3.2 Describe how the research will be minimally invasive or provide a therapeutic benefit that is related to the participants’ condition.*"></q547>
  <q548 input="" question="P3.3 Describe how the research will lead to increased understanding about, or improvements in, the care of people receiving this type of medical care or who are in this condition.*"></q548>
  <q254 input="" question="P4.1 Who will the research involve? *"></q254>
  <q550 input="" question="P4.2 How will the research project accommodate people with a cognitive impairment, an intellectual disability or a mental illness? *"></q550>
  <q551 input="" question="P4.3 How will the participants’ degree of cognitive impairment, intellectual disability or mental illness be assessed?*"></q551>
  <q552 input="" question="P4.4 How will you assess whether participants’ cognitive impairment, intellectual disability or mental illness increases their susceptibility to discomfort or distress? *"></q552>
  <q554 input="" question="P5.1 Describe any potentially detrimental effects on people in dependent or unequal relationships who may participate in your research, and how will you manage them.*"></q554>
  <q323 input="" question="P6.1 Is the research designed to discover or expose illegal activity? *"></q323>
  <q942 input="" question="P6.1.1.1 Although the research is not designed to discover illegal activity, is it likely or foreseeable that illegal activity will be discovered? *"></q942>
  <q327 input="" question="P6.1.2.1 Does the illegal activity bear on the discharge of a public responsibility or the fitness to hold public office? *"></q327>
  <q325 input="" question="P6.2 Will you or your institution have a legal duty to disclose information about illegal activity that is discovered?*"></q325>
  <q556 input="" question="P6.2.1 How will the duty to disclose this information be managed?*"></q556>
  <q328 input="" question="P6.3 Will you have contact, in a professional role, other than as a researcher, with people who may be involved in illegal activities? *"></q328>
  <q557 input="" question="P6.3.1 How will you ensure that the research is not compromised by contact in that professional role and that obligations to participants related to that role will not be compromised by the research?*"></q557>
  <q941 input="" question="P6.4 Will the research involve participants who are subject to criminal justice processes? *"></q941>
  <q558 input="" question="P7.1 How will local cultural values be acknowledged and reflected in both the design of the research and the conduct of researchers?*"></q558>
  <q559 input="" question="P7.2 How will the design of the research take into account local power relations, inequalities and divisions?*"></q559>
  <OtherCountriesRpt input="">
    <q818 input="" question="P7.3.1 Name of the country.*"></q818>
    <q819 input="" question="P7.3.2 Is there an ethics review process?*"></q819>
    <q821 input="" question="P7.3.2.1 Will the Australian review body’s approval of the research need to be reported to a local body?*"></q821>
    <q826 input="" question="P7.3.2.2 Identify the local ethics guidelines that will be used for reviewing the research in this country.*"></q826>
  </OtherCountriesRpt>
  <q562 input="" question="P7.4 Describe any factors that may make it problematic to conform to ethical standards expressed in the National Statement and what steps will be taken to address these matters.*"></q562>
  <q369 input="" question="P7.5 Do you plan to engage individuals from any country in which the research will be conducted to help conduct the research? *"></q369>
  <q563 input="" question="P7.5.1 Who do you intend to engage and how will you employ them? *"></q563>
  <q564 input="" question="P7.5.2 How will the capacity and expertise of these individuals to conduct the research be assessed?*"></q564>
  <q565 input="" question="P7.5.3 How will you ensure that these individuals conduct the research in a manner that accords participants no less respect and protection than the National Statement requires? *"></q565>
  <q566 input="" question="P7.6 To whom will participants direct any questions, concerns or complaints about the research?*"></q566>
  <q567 input="" question="P7.7 How will you engage with participants and their communities with respect to their expectations of the research project? *"></q567>
  <q1419 input="" question="P7.8 How will you manage these expectations in light of any resource limitations of the research project?*"></q1419>
  <q568 input="" question="P8.1 How have you considered and addressed local Aboriginal and Torres Strait Islander cultural values in the design and conduct of this research?*"></q568>
  <q569 input="" question="P8.2 Describe the process that will be used to satisfy the requirements for community consultation, engagement and governance that apply to your research?*"></q569>
  <q570 input="" question="P8.3 List any relevant ethics guidelines that you have consulted during the development of your research project.*"></q570>
  <q572 input="" question="Q2.1.1 Indicate how you will identify and recruit participants for your research, referencing any relevant section/s of your Project Description/Protocol.*"></q572>
  <q573 input="" question="Q2.1.2 How will your recruitment strategy take account of the ethical considerations relevant to the specific people you are recruiting?*"></q573>
  <q859 input="" question="Q2.1.M1.1 Describe the co-researchers for your project and how they will be identified, approached and added to the cohort.*"></q859>
  <q860 input="" question="Q2.1.M1.2 Will there be any participants or stakeholders involved in your research who will not be co-researchers? *"></q860>
  <q530 input="" question="Q2.1.M7.1 How will you distinguish between participants and non-participants in your research, and how will you manage that distinction? *"></q530>
  <q529 input="" question="Q2.1.M7.2 How will you determine whether it is appropriate to obtain consent from the people whom you are observing?*"></q529>
  <q716 input="" question="Q2.2.1 Indicate the relevant section/s of your Project Description/Protocol that address/es consent.*"></q716>
  <q167 input="" question="Q2.2.2 Will you be obtaining consent from some or all participants to participate in the research?*"></q167>
  <q168 input="" question="Q2.2.2.1 What is the scope of consent that you will be seeking?*"></q168>
  <q169 input="" question="Q2.2.2.2 How will consent be obtained?*"></q169>
  <q170 input="" question="Q2.2.2.3 Are you proposing to obtain consent using limited disclosure?*"></q170>
  <q171 input="" question="Q2.2.2.3.1 Are you proposing to obtain consent using active concealment or planned deception?*"></q171>
  <q978 input="" question="Q2.2.2.3.1.1.1 How will you ensure that the research meets the guidance provided in National Statement 2.3.1 regarding the use of limited disclosure without active concealment or planned deception?*"></q978>
  <q980 input="" question="Q2.2.2.3.1.2.1 How will you ensure that the research meets the guidance provided in National Statement 2.3.2 regarding the use of limited disclosure with active concealment or planned deception?*"></q980>
  <q172 input="" question="Q2.2.3 Are family members, authorised representatives or any others involved in the participants’ decision to participate in the research? *"></q172>
  <q576 input="" question="Q2.2.3.1 Outline the family members, authorised representatives or others that will be involved in the decision to participate in the research and the extent of their involvement. *"></q576>
  <q178 input="" question="Q2.2.P1.P3.1 Will the process of providing information and obtaining consent from the participants be separate from obtaining consent for non-research purposes (such as for a clinical procedure)?*"></q178>
  <q1003 input="" question="Q2.2.P1.P3.1.1.1 How will you ensure that these processes are separate?*"></q1003>
  <q1002 input="" question="Q2.2.P1.P3.1.2.1 Justify why these processes will not be separate.*"></q1002>
  <q993 input="" question="Q2.2.4 Will there be an opportunity to confirm or re-negotiate consent during the research project?*"></q993>
  <q1429 input="" question="Q2.2.5 Has consent been obtained from participants for the use of their data in the proposed research? *"></q1429>
  <q1432 input="" question="Q2.2.5.1.1 How has consent for use (or secondary use) of the data been obtained?*"></q1432>
  <q1433 input="" question="2.2.5.2.1 Explain why consent for use (or secondary use) of the data has not been obtained?*"></q1433>
  <q577 input="" question="Q2.2.6 Describe any ethical considerations related to the approach to consent that you will be seeking and your strategies for addressing and managing these issues.*"></q577>
  <q176 input="" question="Q2.2.7 Are you proposing to use an opt-out approach with respect to some or all participants?*"></q176>
  <q987 input="" question="Q2.2.7.1 How will you ensure that the research meets the guidance for approving an opt-out approach, as listed in National Statement 2.3.6?*"></q987>
  <q177 input="" question="Q2.2.8 Are you requesting a waiver of the requirement for consent with respect to some or all participants?*"></q177>
  <q990 input="" question="Q2.2.8.1 How will you ensure that the research satisfies the guidance for waiving consent as listed in National Statement 2.3.10?*"></q990>
  <q579 input="" question="Q2.2.8.P6.1 How will you ensure that the research meets the guidance provided in National Statement 2.3.11 regarding waiving consent for research aiming to expose illegal activity?*"></q579>
  <q997 input="" question="Q2.2.M5.1 Describe how you will determine whether it is appropriate to obtain consent from people whom you encounter and intend to write about.*"></q997>
  <q1087 input="" question="Q2.2.M5.2 Describe how and when you will obtain consent. *"></q1087>
  <q1008 input="" question="Q2.2.P2.1 From whom are you obtaining consent?*"></q1008>
  <q1011 input="" question="Q2.2.P2.1.1 As consent is only being sought from the young person, justify how the research will comply with the requirements of National Statement 4.2.8 and National Statement 4.2.9?*"></q1011>
  <q1004 input="" question="Q2.2.P2.2 Will the research involve the participation of any children who are not of sufficient maturity to consent? *"></q1004>
  <q1005 input="" question="Q2.2.P2.3 Explain how the children or young people's capacity to consent will be judged.*"></q1005>
  <q1010 input="" question="Q2.2.P2.4 Describe how you plan to discuss the research project with children at their level of comprehension.*"></q1010>
  <q213 input="" question="Q2.2.P2.5 Are you proposing to obtain consent using standing parental consent for the participation of the children or young people?*"></q213>
  <q239 input="" question="Q2.2.P3.1 Will some or all of the participants have impaired capacity to provide consent for participation in the research? *"></q239>
  <q240 input="" question="Q2.2.P3.1.1 Are you intending to commence the research without prior consent from the participants or authorised representatives as per National Statement 4.4.13?*"></q240>
  <q584 input="" question="Q2.2.P3.1.2 How will you communicate with and/or obtain consent from the participants’ carers, their families, their guardian and/or other responsible persons?*"></q584>
  <q583 input="" question="Q2.2.P3.2 Describe how the process of obtaining consent (or not obtaining consent) is consistent with the processes outlined in National Statement 4.4.9-14.*"></q583>
  <q582 input="" question="Q2.2.P4.1 Describe the process that you will use to determine a person’s capacity to provide consent to participate in the research if that person has a cognitive impairment, intellectual disability or mental illness.*"></q582>
  <q581 input="" question="Q2.2.P4.2 Describe how the process of obtaining consent is consistent with the requirements outlined in National Statement 4.5.5-11 regarding having respect for participants with a cognitive impairment, an intellectual disability, or a mental illness.*"></q581>
  <q580 input="" question="Q2.2.P6.1 How will you ensure that participants are aware of the likelihood that illegal activity may be discovered and any duty that you may have to disclose information about illegal activity that is discovered? *"></q580>
  <q585 input="" question="Q2.3.1 Describe the risks and burdens associated with your research, referencing any relevant sections of your Project Description/Protocol as appropriate.*"></q585>
  <q586 input="" question="Q2.3.2 Describe how these risks will be mitigated and managed.*"></q586>
  <q968 input="" question="Q2.3.P5.1 How will you ensure that a person declining to participate in, or deciding to withdraw from, research will not suffer any negative consequences?*"></q968>
  <q587 input="" question="Q2.4.1 Describe the benefits associated with your research, referencing any relevant sections of your Project Description/Protocol as appropriate.*"></q587>
  <q588 input="" question="Q2.4.2 Explain how the benefits of this research justify any risks or burdens associated with the research. *"></q588>
  <q589 input="" question="Q2.4.3 How will you manage participants’ expectations of the perceived benefit of participating in the research? *"></q589>
  <q436 input="" question="Q3.1 Indicate the type of information/data you will be collecting for this project. *"></q436>
  <q438 input="" question="Q3.2 Indicate the type of information/data you will be using in this project. *"></q438>
  <q441 input="" question="Q3.3 Indicate the degree of identifiability of information/data you will be collecting for this project. *"></q441>
  <q443 input="" question="Q3.4 Indicate the degree of identifiability of information/data you will be using in this project. *"></q443>
  <q592 input="" question="Q3.5 Describe any ethical considerations relating to the collection and/or use of the information/data in this project.*"></q592>
  <q448 input="" question="Q3.6 Identify the source/s of the information/data that you will be collecting and/or using in this project.*"></q448>
  <q1641 input="" question="Q3.6.1 Has the data custodian/s, if any, agreed to provide access to the data for use in the proposed research?"></q1641>
  <q1644 input="" question="Q3.6.2 Provide any supporting letter or material. Optional"></q1644>
  <q593 input="" question="Q3.7 Describe any ethical considerations relating to the source of information/data as indicated in the response to the previous question.*"></q593>
  <q453 input="" question="Q3.8 Was the information/data that you are using previously collected for a purpose other than research?*"></q453>
  <q594 input="" question="Q3.8.1 Provide a rationale for your use of information/data for a purpose other than that for which it was originally collected.*"></q594>
  <q455 input="" question="Q3.9 Do you plan to disclose any personal information/data in this project to a third party?*"></q455>
  <q596 input="" question="Q3.9.1 To whom do you plan to disclose the personal information/data? *"></q596>
  <q595 input="" question="Q3.9.2 Describe how you will protect the privacy of the participants and the security of the personal information/data that you will be disclosing?*"></q595>
  <q1024 input="" question="Q3.10 How will you protect the privacy of participants and non-participants in any notes and/or publications arising from your research?*"></q1024>
  <q1025 input="" question="Q3.11 Are there any restrictions on your ability to assure the confidentiality of participants?*"></q1025>
  <q597 input="" question="Q3.11.1 Describe how you will explain to participants the restrictions on your ability to give them an assurance of confidentiality. *"></q597>
  <q459 input="" question="Q3.12 Do you plan to share any individual research results obtained during this research to the participants?*"></q459>
  <q598 input="" question="Q3.12.1 Describe any ethical considerations relating to the sharing of individual research results with the participants. *"></q598>
  <q599 input="" question="Q3.13 Describe how you will handle any secondary or incidental findings that arise from the analysis of personal information/data. *"></q599>
  <q600 input="" question="Q3.14 Describe how the information/data will be stored, accessed, archived and/or destroyed. *"></q600>
  <q601 input="" question="Q3.15 Describe any ethical considerations relating to the storage of, access to or destruction of information/data in this project.*"></q601>
  <q467 input="" question="Q3.16 Will the outcomes of this project be disseminated to the participants?*"></q467>
  <q1405 input="" question="Q3.16.1.1 Describe how the outcomes of the project will be disseminated to the participants, or refer to the relevant section/s of your Project Description/Protocol which deals with this matter. *"></q1405>
  <q602 input="" question="Q3.16.1.2 Describe any ethical considerations relating to any dissemination of outcomes to the participants. *"></q602>
  <q1030 input="" question="Q3.16.2.1 Justify why the outcomes of this project will not be disseminated to the participants. *"></q1030>
  <q603 input="" question="Q3.17 Describe any foreseeable future activities for which information/data collected and/or used in this project may be made available.*"></q603>
  <q604 input="" question="Q3.18 Describe any ethical considerations relating to the planned or possible future use of information/data in this project. *"></q604>
  <q737 input="" question="Q4.1 Attach the Project Description/Protocol to your HREA. *"></q737>
  <q1222 input="" question="Q4.2 Are there any other relevant documents associated with conducting your research project?"></q1222>
  <OtherAttachmentsRpt input="">
    <q1082 input="" question="Q4.2.1 Upload attachment*"></q1082>
    <q621 input="" question="Q4.2.2 Description of attachment*"></q621>
  </OtherAttachmentsRpt>
  <q678 input="" question="Q4.3 Select the Organisation that hosts the HREC or other review body. *"></q678>
  <q481 input="" question="Q4.4 Select the HREC or other body to which you are applying from the list below.*"></q481>
  <q1251 input="" question="Q4.5 Under which review pathway are you intending to submit this application?*"></q1251>
  <q1407 input="" question="Q4.6 Will this application be reviewed under the National Mutual Acceptance scheme?*"></q1407>
  <TeamMemberDeclarationRpt input="">
    <q733 input="" question="I, Dr Test User, certify that:"></q733>
    <q725 input="" question="Q4.7 How will Dr Test User agree to these terms?*"></q725>
    <q640 input="" question="Signature *"></q640>
    <q732 input="" question="Upload Signature*"></q732>
  </TeamMemberDeclarationRpt>
  <q642 input="" question="Is your application complete and have you attached the Project Description/Protocol and any relevant supporting documents? *"></q642>
  <q680 input="" question="Verify that you are ready to generate your HREA document."></q680>
  <TEST1 input=""></TEST1>
  <TEST2 input=""></TEST2>
</Application>